Abstract
Corn silk, a traditional Chinese medicine, has been found to exert an antihypertensive effect in clinical practice and trials. However, systematic review of current evidence on this topic was not available. Thus, this study aims to assess safety and efficacy of corn silk tea (CST) in improving clinical outcomes in patients with hypertension. A systematic literature search was conducted through popular electronic databases up to October 2018. Randomized controlled trials (RCTs) comparing CST plus conventional antihypertensive drugs with conventional antihypertensive drugs alone were included. The main outcome was total blood pressure lowering efficacy. The risk of bias assessment according to the Cochrane Handbook was used to evaluate the methodological quality of the included trials. Review Manager 5.3 software was used for data analyses. Five RCTs involving 567 participants were included. Due to the poor quality of methodologies of most trials, limited evidence showed that CST plus antihypertensive drugs might be more effective in lowering blood pressure compared with antihypertensive drugs alone (RR = 1.27; 95% CI: 1.17 to 1.38, P<0.00001; heterogeneity: P = 0.51, I
2
= 0%, fixed-effect model). However, there is no evidence ...Continue Reading
References
Apr 29, 1998·Controlled Clinical Trials·A VickersR Rees
Nov 9, 2002·Lancet·Majid EzzatiUNKNOWN Comparative Risk Assessment Collaborating Group
Dec 21, 2002·Lancet·Sarah LewingtonUNKNOWN Prospective Studies Collaboration
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jan 6, 2006·Wiener medizinische Wochenschrift·Edzard Ernst
Nov 18, 2006·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Ronny A BellThomas A Arcury
Aug 29, 2007·Phytotherapy Research : PTR·Darius Arthur FarsiJohn Thor Arnason
May 6, 2008·Lancet·Carlene M M LawesUNKNOWN International Society of Hypertension
Jul 28, 2009·Journal of Clinical Epidemiology·David MoherUNKNOWN PRISMA Group
Nov 20, 2009·Kidney International·Rigas G Kalaitzidis, George L Bakris
Dec 24, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Jie Wang, Xingjiang Xiong
Jun 14, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Ulrich Kintscher
Jul 19, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Jie Wang, Xingjiang Xiong
Jul 22, 2014·The Journal of Clinical Hypertension·Norm R C CampbellUNKNOWN International Society of Hypertension Executive Committee
Apr 3, 2015·Lancet·Neil R PoulterMark Caulfield
Jan 30, 2016·BMC Medicine·Edwin Michael, Brajendra K Singh
Aug 10, 2016·Circulation·Katherine T MillsJiang He
Jan 10, 2017·Journal of Agricultural and Food Chemistry·Tin-Yun HoChien-Yun Hsiang
Jan 18, 2017·JAMA : the Journal of the American Medical Association·Mohammad H ForouzanfarChristopher J L Murray
Feb 23, 2017·Scientific Reports·Xingjiang XiongXiaoke Li
Jun 25, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Chang Won LeeYong Il Park
Mar 3, 2018·Scientific Reports·Hui PangZhenkun Zong
Jun 1, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Ana LiuJianqing Ju
Jan 10, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Marcin OżarowskiAgnieszka Seremak-Mrozikiewicz